Cargando…

Effects of Immunosuppressants on Immune Response to Vaccine in Inflammatory Bowel Disease

OBJECTIVE: To evaluate the response rate to vaccination in different treatment groups (nonimmunosuppressants and immunosuppressants). DATA SOURCES: We completed an online systematic search using PubMed to identify all articles published in English between January 1990 and December 2013 assessing the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yuan, Zhao, Di, Xu, An-Tao, Shen, Jun, Ran, Zhi-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833992/ https://www.ncbi.nlm.nih.gov/pubmed/25758282 http://dx.doi.org/10.4103/0366-6999.152683

Ejemplares similares

Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease
por: Nguyen, Huyen-Tran, et al.
Publicado: (2017)

IMPROVING THE VACCINATION RATES FOR IMMUNOSUPPRESSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Cheng, Tony, et al.
Publicado: (2022)

Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature
por: Cao, Yuan, et al.
Publicado: (2014)

Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy
por: Shirai, Shimpei, et al.
Publicado: (2018)

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
por: Alexander, James L, et al.
Publicado: (2021)

Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease
por: Tran-Minh, My-Linh, et al.
Publicado: (2017)

Immune response to hepatitis B vaccination in pediatric patients with inflammatory bowel disease
por: BARANOWSKA-NOWAK, MARTA, et al.
Publicado: (2020)

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients
por: Alexander, James L., et al.
Publicado: (2023)

Up-regulation and Pre-activation of TRAF3 and TRAF5 in Inflammatory Bowel Disease
por: Shen, Jun, et al.
Publicado: (2013)

Risk of Uveitis in Patients With Inflammatory Bowel Disease on Immunosuppressive Drug Therapy
por: Barberio, Julie, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
por: Alexander, James L, et al.
Publicado: (2021)

Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment
por: Plasencia-Rodríguez, Chamaida, et al.
Publicado: (2023)

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020)

Enterocytozoon Bieneusi Infects Children With Inflammatory Bowel Disease Undergoing Immunosuppressive Treatment
por: Zajączkowska, Żaneta, et al.
Publicado: (2021)

Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation
por: Singh, Urvashi, et al.
Publicado: (2022)

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
por: Alexander, James L, et al.
Publicado: (2022)

Serological Investigation of Food Specific Immunoglobulin G Antibodies in Patients with Inflammatory Bowel Diseases
por: Cai, Chenwen, et al.
Publicado: (2014)

Su1611: POOR RESPONSE TO ANTI-SARS-COV-2 VACCINATION IN IMMUNOSUPPRESSED INFLAMMATORY BOWEL DISEASE PATIENTS IS ASSOCIATED WITH ALTERED GUT MICROBIOTA FUNCTION
por: Alexander, James L., et al.
Publicado: (2022)

Application of Zebrafish Models in Inflammatory Bowel Disease
por: Hanyang, Li, et al.
Publicado: (2017)

Different therapeutic approaches on quality of life in patients with inflammatory bowel disease
por: Xu, Junjie, et al.
Publicado: (2014)

Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy
por: Giagkou, Eftychia, et al.
Publicado: (2018)

Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
por: Kappelman, Michael D., et al.
Publicado: (2021)

Vaccination therapy for inflammatory bowel disease
por: Liu, Yafei, et al.
Publicado: (2023)

NUDT15 genotyping during azathioprine treatment in patients with inflammatory bowel disease: implications for a dose-optimization strategy
por: Xu, Ye, et al.
Publicado: (2020)

The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study
por: Ding, Zhao-Hui, et al.
Publicado: (2021)

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study
por: Alexander, James L, et al.
Publicado: (2022)

Different Activation of TRAF4 and TRAF6 in Inflammatory Bowel Disease
por: Shen, Jun, et al.
Publicado: (2013)

Prevalence of Fatigue and Unrecognized Depression in Patients with Inflammatory Bowel Disease in Remission under Immunosuppressants and Biologicals
por: Truyens, Marie, et al.
Publicado: (2021)

Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease
por: Calafat, Margalida, et al.
Publicado: (2021)

Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment
por: Axiaris, Georgios, et al.
Publicado: (2021)

Hepatitis E Virus Infection in Patients with Chronic Inflammatory Bowel Disease Treated with Immunosuppressive Therapy
por: Kounis, Ilias, et al.
Publicado: (2023)

Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study
por: Wasserbauer, Martin, et al.
Publicado: (2022)

Serum Anti-Spike Antibodies Are Not Affected by Immunosuppressants in SARS-CoV-2 Vaccinations Given to Brazilian Patients with Inflammatory Bowel Disease
por: Pereira, Magno Luís Costa, et al.
Publicado: (2023)

Immune response modulation in inflammatory bowel diseases by Helicobacter pylori infection
por: Feilstrecker Balani, Gabriella, et al.
Publicado: (2023)

Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations
por: Bezzio, Cristina, et al.
Publicado: (2022)

Immune Cell Landscaping Reveals Distinct Immune Signatures of Inflammatory Bowel Disease
por: Bai, Xiaowu, et al.
Publicado: (2022)

Vaccination and infection prevention in inflammatory bowel disease
por: Vermeire, Severine, et al.
Publicado: (2010)

Dietary Regulation of the Crosstalk between Gut Microbiome and Immune Response in Inflammatory Bowel Disease
por: Yao, Qianqian, et al.
Publicado: (2021)

Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
por: Khan, Nabeel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0726qee9htm96oibgt2l37jh4j